Skip to main content
PRVA
NASDAQ Industrial Applications And Services

Puma Growth Holdings Reveals 5.07% Stake in Privia Health After $138M Accumulation

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$20.83
Mkt Cap
$2.661B
52W Low
$19.53
52W High
$28.82
52W Position info
6.7% above low
Off High info
28% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

PRVA is trading near its 52-week low of $19.53 (6.7% above the low).

Summary

Puma Growth Holdings and Rubicon Founders disclosed a new 5.07% stake in Privia Health, spending $138.4M with heavy buying in August after Q2 earnings.


Key Events · Ownership and Investor Activity · PRVA

  • 5.07% Stake Disclosed

    Puma Growth Holdings and affiliated Rubicon Founders entities report beneficial ownership of 6,472,513 shares, representing 5.07% of Privia Health's 127.7M outstanding shares.

  • $138.4M Total Investment

    The reporting persons spent approximately $138,436,812 (excluding commissions) to accumulate the position, funded through working capital.

  • Aggressive Post-Earnings Buying

    Purchased 699,991 shares between August 6 and September 1, 2026 at $20.90–$21.00 per share, immediately following Privia's strong Q2 earnings beat on August 6.

  • Prior July Sales at Higher Prices

    Sold 197,557 shares on July 7 and 13, 2026 at $27.21–$27.65 per share, then re-entered at significantly lower prices in August.


Analysis · PRVA · Industrial Applications And Services

Puma Growth Holdings, backed by Rubicon Founders and Adam Boehler, has built a 5.07% position in Privia Health Group, spending approximately $138.4 million. The filing shows a clear pivot: the group sold nearly 200,000 shares in July at prices above $27, then aggressively bought back nearly 700,000 shares in August and early September at prices around $21. This buying came immediately after Privia's strong Q2 earnings report on August 6, suggesting the investors saw the post-earnings price as an attractive entry point. The stake crosses the 5% threshold that requires public disclosure, and the filing's language about reviewing the investment and communicating with management and other stockholders leaves the door open for potential activist engagement.

How filings like this one have moved

In the 30 days to Sep 10, 2026, 30.2% of the 2009 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PRVA was trading at $20.83 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.7B. The 52-week trading range was $19.53 to $28.82. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PRVA - Latest Insights

PRVA
Aug 06, 2026, 8:45 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $24.00
Real-time Price: $20.42 info
Change: -$3.58 (-15%) info
Market Cap: $2.608B info
PRVA
Aug 06, 2026, 6:23 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $24.00
Real-time Price: $20.42 info
Change: -$3.58 (-15%) info
Market Cap: $2.608B info
PRVA
Aug 06, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $24.00
Real-time Price: $20.42 info
Change: -$3.58 (-15%) info
Market Cap: $2.608B info
PRVA
May 07, 2026, 8:58 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $24.71
Real-time Price: $20.42 info
Change: -$4.29 (-17%) info
Market Cap: $2.608B info
PRVA
May 07, 2026, 6:07 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $24.71
Real-time Price: $20.42 info
Change: -$4.29 (-17%) info
Market Cap: $2.608B info